Trial Profile
Effect of Mirabegron (beta 3-adrenergic receptor agonist) on overactive bladder patients : a functional brain imaging study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 14 Feb 2018 Status changed from recruiting to completed.
- 06 Jul 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
- 18 Jul 2014 New trial record